Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Smoking Cessation Interventions on Tuberculosis Treatment Outcomes Among Newly Diagnosed Pulmonary Tuberculosis Patients; a Single Blind Randomized Controlled Trial

NCT04848246 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.

NCT NCT04848246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04848246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Smoking Cessation Interventions on Tuberculosis Treatment Outcomes Among Newly Diagnosed Pulmonary Tuberculosis Patients; a Single Blind Randomized Controlled Trial
Lead sponsor
Dow University of Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2017
Completion date
October 15, 2019
Enrollment
292 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary